Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/all.15381 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effects of the immunoglobulin/histamine complex on panic disorder concurrent with chronic spontaneous urticaria: a case report.
J Med Case Rep
July 2023
Department of Allergy and Clinical Immunology, Cheju Halla General Hospital, Doreongno 65, Jeju-si, Jeju, Republic of Korea.
Article Synopsis
- Panic disorder and chronic spontaneous urticaria (CSU) have been linked, with new treatments like antihistamines and immunoglobulin/histamine complexes showing promise for relief.
- A case study follows a 52-year-old woman who successfully managed her 23-year struggle with both conditions through weekly injections of Histobulin™.
- The patient's progress was tracked using various diagnostic assessments, ultimately leading to her experiencing complete symptom relief after 27 treatments.
Primary eosinophilic colitis (PEC) is a primary eosinophilic gastrointestinal disorder, and immunoglobulin/histamine complex (IHC) may be an effective therapeutic for PEC. IHC has a nonallergen-specific antinociceptive effect in the treatment of histamine-mediated pain.
View Article and Find Full Text PDFThere is no cure for psoriasis. A psoriasis patient was treated with Histobulin™. The patient's clinical symptoms and signs disappeared after the eighth injection and did not recur for more than 18 months.
View Article and Find Full Text PDFEffects of the immunoglobulin/histamine complex in chronic spontaneous urticaria focusing on remission induction.
Allergy
September 2022
Department of Allergy and Clinical Immunology, Cheju Halla General Hospital, Jeju, Korea.
Induction of remission in chronic urticaria by immunotherapy using immunoglobulin/histamine complex (Histobulin™): a case report.
Allergy Asthma Clin Immunol
November 2021
Department of Allergy, Allergy and Clinical Immunology Center, Cheju Halla General Hospital, Doreongno 65, Jeju-si, 63127, Jeju-Si Jeju Special Self-Governing Province, Korea.
Background: Symptom control is a major concern in chronic urticaria. Histobulin™ is a histamine/immunoglobulin complex that has been approved for allergic rhinitis, bronchial asthma and chronic urticaria in some countries. Not only has the immunoglobulin/histamine complex been reported to be effective in allergic diseases, including chronic urticaria, but recently, the possibility of remission induction in chronic urticaria by the immunoglobulin/histamine complex has been reported.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!